After the SARS-CoV-1 outbreak in 2002-2004, numerous evidence suggested a key role of MBL in the first-line response against the virus: MBL was shown to bind SARS-CoV and consequently inhibit SARS-CoV S-protein mediated viral infection (50). The gene discussed is MBL2; the disease is viral infectious disease.